Odonate Therapeutics (ODT) Prices 5.614M Share Common Offering at $14.25/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Odonate Therapeutics Announces Pricing of Public Offering of Shares of Common Stock
August 27, 2020 7:45 PM EDTSAN DIEGO--(BUSINESS WIRE)-- Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer, today announced the pricing of an underwritten public offering of 5,614,036 shares of its common stock, offered at a price of $14.25 per share. In addition, Odonate has granted the underwriters a 30-day option to purchase up to an additional 842,105 shares of its common stock on the same terms and conditions. All shares of common stock sold in the offering are being sold by... More
